Minomic executes agreement with Cirrus Dx

Australia based diagnostic company, Minomic International Ltd has announced that the company has executed an agreement w...

February 19, 2019 | Tuesday | News
Invitrocue appoints Prof Arial Zeng Yi as Patient Derived Organoid Consultant

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Ar...

February 18, 2019 | Monday | News
Mayne Pharma launches anti-plaque psoriasis agent in US

Mayne Pharma Group Limited has announced the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United ...

February 14, 2019 | Thursday | News
Cartherics and panCELLa announce collaborative agreement for cell therapy

Cartherics and panCELLa have announced their collaboration to research, develop and commercialize products for the treat...

February 15, 2019 | Friday | News
SpeeDx submits RespiVirus assay for clinical approval

SpeeDx Pty. Ltd. has announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration ...

February 13, 2019 | Wednesday | News
Invitrocue creates Joint Venture with A*STAR scientist Dr Chen Qingfeng

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue,...

February 12, 2019 | Tuesday | News
“An efficient approach to clinical trial design will have the greatest impact”

The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...

February 6, 2019 | Wednesday | Opinion
Strides to exit investment in Arrow

Strides Pharma Science Limited (Strides) has announced that its step-down subsidiary Strides Pharma Global Pte, Limited,...

February 4, 2019 | Monday | News
The iQ Group Global launches saliva glucose biosensor

The iQ Group Global, a consortium of life science and financial services companies which span the biopharma value chain ...

February 1, 2019 | Friday | News
Mayne Pharma launches Tolsura capsules in the US

Australia-based Mayne Pharma is pleased to announce the launch of TOLSURA (SUBA®-itraconazole) 65mg capsule in the U...

January 30, 2019 | Wednesday | News
Resistance-guided therapy for Gonorrhoea now available

UK patients with N. gonorrhoeae (GC) now have the option of receiving the cheap and easily-administered o...

January 25, 2019 | Friday | News
Novel device to diagnose and treat patients much faster

Scientists from Monash University have developed a new device that can rapidly screen the blood in just minutes to detec...

January 23, 2019 | Wednesday | News
Invitrocue declares changes in board

Invitrocue Limited, a leading healthcare bio-analytic solutions provider, announces the appointment of Dr. Steven Fang a...

January 9, 2019 | Wednesday | News
Immutep collaborates with CYTLIMIC

Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...

January 8, 2019 | Tuesday | News
Scientists discover a molecule that predicts patient's ability to survive melanoma

Doctors may be able to assess the survival rates of melanoma patients following the discovery of a molecule that allows ...

January 2, 2019 | Wednesday | News
Patrys's drug suppresses breast cancer brain metastases, increases survival

Singapore -  Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...

December 24, 2018 | Monday | News
Australian researchers to start clinical trials for dementia ultrasound treatment

Safety testing of a pioneering ultrasound technique that could delay the effects of dementia will begin in Brisbane late...

December 20, 2018 | Thursday | News
NeuClone discloses its sixth biosimilar candidate of Pertuzumab

NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing h...

December 18, 2018 | Tuesday | News
Novotech CRO launches largest Oracle TMMCS in APAC

Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has i...

December 17, 2018 | Monday | News
“Diabetic kidney disease could overwhelm our health systems”: Dr Richard Lipscombe

Globally, the diabetic nephropathy market is witnessing significant growth due to rise in the incidence of diabetes and ...

December 17, 2018 | Monday | Opinion
Mayne Pharma receives FDA approval of Tolsura

Australia-based Mayne Pharma announced that the US FDA has approved the New Drug Application (NDA) for Tolsura 65mg...

December 12, 2018 | Wednesday | News
Sienna embarks on ambitious M&A strategy

Singapore - ASX-listed, cancer diagnostics company, Sienna, has emerging cancer diagnostics in sight as it embarks on M&...

December 11, 2018 | Tuesday | News
APLIDIN gets world-first approval for Multiple Myeloma

Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat th...

December 11, 2018 | Tuesday | News
Australian researchers develop novel technology for cancer detection

A group of researchers from the University of Queensland, Australia has developed a new method that will enable quick an...

December 5, 2018 | Wednesday | News
BlackBerry to help improve digital infrastructure for healthcare

Singapore – BlackBerry Limited announced it has become a HIMSS Analytics Certified Consultant to help address the ...

December 3, 2018 | Monday | News